Japan · Biopharma startup
Japan · SiccaNova Therapeutics
SiccaNova Therapeuticsis a startup developing novel low-molecular therapeutics targeting dry mouth (xerostomia) and dry eye conditions.
Funding reportedLast round: Series A
What company datasets say SiccaNova Therapeutics raised
Funding, as reported
Reported in all7.9Min the source's currency
Last roundSeries A
Investors listed5
On a portfolio page
Investors who name them
Each firm lists SiccaNova Therapeutics on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Biopharma in Japan
Startups like it
Is this your company?
Add your raise, your deck and your story, and put SiccaNova Therapeutics in front of investors. Or tell us what we have wrong.